Patents by Inventor John Bantick

John Bantick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted fused pyridazinone compounds; composition and use thereof
    Patent number: 6770646
    Abstract: The invention provides certain pyrrolo-, thieno-, furano-and pyrazolo-[3,4-d]-pyridazinones, processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and methods of treatment involving their use.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: August 3, 2004
    Assignee: AstraZeneca AB
    Inventors: John Bantick, Martin Cooper, Philip Thorne, Matthew Perry
  • Thieno[2,3-d]pyrimidinediones and their use as pharmaceuticals
    Publication number: 20040014634
    Abstract: The invention provides thieno[2,3-d]pyrimidinediones of general formula (I), wherein R, R1, R2 and R3 are as defined in the specification, processes for their production, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: June 27, 2003
    Publication date: January 22, 2004
    Inventors: John Bantick, Anthony Ingall, Matthew Perry, Rachel Reynolds
  • Novel compounds
    Publication number: 20020099055
    Abstract: The invention provides certain pyrrolo-, thieno-, furano-and pyrazolo-[3,4-d]-pyridazinones, processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and methods of treatment involving their use.
    Type: Application
    Filed: December 10, 2001
    Publication date: July 25, 2002
    Applicant: AstraZeneca AB.
    Inventors: John Bantick, Martin Cooper, Philip Thorne, Matthew Perry
  • Compounds
    Patent number: 6342601
    Abstract: The invention provides certain pyrrolo-, thieno-, furano- and pyrazolo-[3,4-d]pyridazinones, processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and methods of treatment involving their use.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: January 29, 2002
    Assignee: AstraZeneca AB
    Inventors: John Bantick, Martin Cooper, Philip Thorne, Matthew Perry
  • Thieno[2,3-d]pyrimidine-2,4-diones
    Patent number: 6300334
    Abstract: Compounds of formula (I): wherein R1, R2, and R3 are defined in the specification. The compounds are useful for treating or reducing the risk of reversible obstructive airways disease.
    Type: Grant
    Filed: October 13, 1999
    Date of Patent: October 9, 2001
    Assignee: AstraZeneca AB
    Inventors: John Bantick, Martin Cooper, Matthew Perry, Philip Thorne
  • Pyridazine compounds
    Patent number: 5935956
    Abstract: The invention relates to fused pyridazine compounds, in particular pyrido ?h!cinnoline, pyrido?h!cinnolinone, pyridocyclopenta?1,2-c!pyridazine, pyridocyclopenta?1,2-c!pyridazinone, pyridocyclohepta?1,2-c!pyridazine and pyridocyclohepta?1,2-c!pyridazinone derivatives, their use as medicaments and pharmaceutical compositions comprising them.
    Type: Grant
    Filed: September 5, 1997
    Date of Patent: August 10, 1999
    Assignee: Astra Pharmaceuticals Ltd.
    Inventors: John Bantick, Simon Hirst, Matthew Perry